US Map / Colorado
State CO

Clinical Trials in Colorado

Recruiting clinical trials with at least one study location in Colorado. Data updated daily from ClinicalTrials.gov.

Total Trials
241
Recruiting Now
241
← Back to US Map
Top Conditions in Colorado
Breast Cancer (7)NSCLC (5)Endometrial Cancer (5)Prostate Cancer (4)Esophageal Adenocarcinoma (4)Colorectal Cancer (4)Lung Cancer (4)Coronary Artery Disease (3)Non-Small Cell Lung Cancer (3)Ovarian Cancer (3)Cervical Cancer (3)Cardiovascular Diseases (3)
NCT05885698 N/A
Recruiting
MYLUNG Consortium Part 3: Observational Study
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
7,500 pts
Location
United States
Sponsor
US Oncology Research
View Trial →
NCT06667700 Phase 3
Recruiting
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Dise...
Condition
Coronavirus Disease (COVID-19)
Enrollment
3,082 pts
Location
United States, Argentina, Brazil
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05767671 N/A
Recruiting
Macrophage Programing in Acute Lung Injury: MiniBAL
Condition
Acute Respiratory Distress Syndrome
Enrollment
56 pts
Location
United States
Sponsor
William Janssen, MD
View Trial →
NCT05780034 Phase 1
Recruiting
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Condition
Relapsed/Refractory B-cell Malignancies
Enrollment
60 pts
Location
United States
Sponsor
Accutar Biotechnology Inc
View Trial →
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03375307 Phase 2
Recruiting
Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread...
Condition
Advanced Bladder Carcinoma
Enrollment
60 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT02012699 N/A
Recruiting
Integrated Cancer Repository for Cancer Research
Condition
Pancreatic Cancer
Enrollment
999,999 pts
Location
United States
Sponsor
University of Nebraska
View Trial →
NCT06127407 Phase 3
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chon...
Condition
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Enrollment
136 pts
Location
United States, Australia, Belgium
Sponsor
Servier Bio-Innovation LLC
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06254898 N/A
Recruiting
Use of Incentives for Stressful Medical Procedures
Condition
Healthy
Enrollment
187 pts
Location
United States
Sponsor
Jennifer Staab, MS, CCLS
View Trial →
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
1,000 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
View Trial →
NCT07284667 Phase 2
Recruiting
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant...
Condition
Major Depressive Disorder (MDD)
Enrollment
153 pts
Location
United States
Sponsor
ACADIA Pharmaceuticals Inc.
View Trial →
NCT07332000 Phase 2
Recruiting
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagen...
Condition
Prostate Cancer Patients Treated by Radiotherapy
Enrollment
45 pts
Location
United States
Sponsor
Candel Therapeutics, Inc.
View Trial →
NCT05469893 Phase 2
Recruiting
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
Condition
High-risk Smoldering Multiple Myeloma
Enrollment
52 pts
Location
United States
Sponsor
Irene Ghobrial, MD
View Trial →
NCT00477100 N/A
Recruiting
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Ti...
Condition
Inflammatory Breast Carcinoma
Enrollment
1,200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT06050252 Phase 2
Recruiting
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resecta...
Condition
Resectable Intrahepatic Cholangiocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
Page 10 of 10 — 241 trials total
← Prev